Mathijs Baens

4.7k total citations · 1 hit paper
51 papers, 3.7k citations indexed

About

Mathijs Baens is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Mathijs Baens has authored 51 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Immunology and 15 papers in Cancer Research. Recurrent topics in Mathijs Baens's work include Lymphoma Diagnosis and Treatment (14 papers), NF-κB Signaling Pathways (13 papers) and Ubiquitin and proteasome pathways (10 papers). Mathijs Baens is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), NF-κB Signaling Pathways (13 papers) and Ubiquitin and proteasome pathways (10 papers). Mathijs Baens collaborates with scholars based in Belgium, United States and France. Mathijs Baens's co-authors include Peter Marynen, Iwona Włodarska, Herman Van den Berghe, Pieter J. Peeters, Judith Dierlamm, Christiane De Wolf‐Peeters, Anne Hagemeijer, Josiane Grosgeorge, Dieter K. Hossfeld and Heidi Noels and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mathijs Baens

51 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

1999 530 citations Judith Dierlamm, Mathijs Baens et al. Blood profile →

Peers

Countries citing papers authored by Mathijs Baens

Since Specialization

Citations

This map shows the geographic impact of Mathijs Baens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathijs Baens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathijs Baens more than expected).

Fields of papers citing papers by Mathijs Baens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathijs Baens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathijs Baens. The network helps show where Mathijs Baens may publish in the future.

Co-authorship network of co-authors of Mathijs Baens

This figure shows the co-authorship network connecting the top 25 collaborators of Mathijs Baens. A scholar is included among the top collaborators of Mathijs Baens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathijs Baens. Mathijs Baens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein 2020 ·Journal of Clinical Investigation ·Jing Cheng, Linda R. Klei, (unknown), Ming Zhang, Rebekka Schairer, Lisa M. Maurer, (unknown), (unknown), Vincent J. Concel, Phillip C. Delekta, Eric V. Dang, Michelle A. Mintz, Mathijs Baens, Jason G. Cyster, Narayanan Parameswaran, Margot Thome, Peter C. Lucas, Linda M. McAllister‐Lucas	15
2	MALT1 Auto-Proteolysis Is Essential for NF-κB-Dependent Gene Transcription in Activated Lymphocytes 2014 ·PLoS ONE ·Mathijs Baens, (unknown), (unknown), (unknown), S.D. Weeks, (unknown), Ewa Nilsson, Robert Roth, Margot Thome, Peter Marynen	58
3	The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling 2013 ·Oncogene ·Shaun Rosebeck, Aasia Rehman, Ingrid J. Apel, Dawn Kohrt, Alex Appert, Michael A. O’Donnell, Adrian T. Ting, MQ Du, Mathijs Baens, Peter C. Lucas, Linda M. McAllister‐Lucas	25
4	Recurrent breakpoints in 14q32.13/TCL1Aregion in mature B-cell neoplasms with villous lymphocytes 2012 ·Leukemia & lymphoma ·(unknown), Mathijs Baens, Lucienne Michaux, Thomas Tousseyn, Katrina Rack, (unknown), José Luis Ferreiro, Peter Van Loo, (unknown), Daan Dierickx, Hilde Demuynck, André Delannoy, Johan Verschuere, Marie Jarošová, Chris De Wolf‐Peeters, Peter Vandenberghe, Iwona Włodarska	2
5	DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma 2010 ·British Journal of Cancer ·(unknown), Nelofer Syed, (unknown), Paul J. Smith, Beverly E. Griffin, Mathijs Baens, M Bai, Konstantinos L. Bourantas, Justin Stebbing, Kikkeri N. Naresh, (unknown), Mark Tuthill, Mark Bower, Eleftheria Hatzimichael, Tim Crook	25
6	Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs 2010 ·Modern Pathology ·Xavier Sagaert, Thomas Tousseyn, Vera Vanhentenrijk, Peter Van Loo, Mathijs Baens, Peter Marynen, Gert De Hertogh, Karel Geboes, Christiane De Wolf‐Peeters	5
7	Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma 2009 ·PLoS ONE ·Heidi Noels, (unknown), Hongxiang Liu, Hongtao Ye, Ming‐Qing Du, Christiane De Wolf‐Peeters, Peter Marynen, Mathijs Baens	6
8	T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20 2008 ·Nature Immunology ·Beatrice Coornaert, Mathijs Baens, Karen Heyninck, (unknown), Mira Haegman, Jens Staal, Lijun Sun, Zhijian J. Chen, Peter Marynen, Rudi Beyaert	351
9	A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-κB Activation by API2·MALT1 Fusions 2007 ·Journal of Biological Chemistry ·Heidi Noels, Geert Loo, (unknown), (unknown), Rudi Beyaert, Peter Marynen, Mathijs Baens	79
10	Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination 2006 ·Cancer Research ·Mathijs Baens, Sabine Fevery, Xavier Sagaert, Heidi Noels, (unknown), (unknown), An Billiau, Christiane De Wolf‐Peeters, Peter Marynen	57
11	Structure of theMLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type 2000 ·Genes Chromosomes and Cancer ·Mathijs Baens, Anja Steyls, Judith Dierlamm, Chris De Wolf‐Peeters, Peter Marynen	37
12	Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia 2000 ·The Hematology Journal ·Gilles Hetet, Hélène Dastot, Mathijs Baens, A. Brizard, F Sigaux, Bernard Grandchamp, Marc‐Henri Stern	17
13	A Physical, Transcript, and Deletion Map of Chromosome Region 12p12.3 Flanked byETV6andCDKN1B:Hypermethylation of theLRP6CpG Island in Two Leukemia Patients with Hemizygous del(12p) 1999 ·Genomics ·Mathijs Baens, Iwona Włodarska, Anniek Corveleyn, (unknown), Anne Hagemeijer, Peter Marynen	29
14	Fluorescence In Situ Hybridization Characterization of New Translocations Involving TEL (ETV6) in a Wide Spectrum of Hematologic Malignancies 1998 ·Blood ·Iwona Włodarska, Roberta La Starza, Mathijs Baens, Judith Dierlamm, (unknown), Dominik Selleslag, (unknown), Cristina Mecucci, Anne Hagemeijer, Herman Van den Berghe, Peter Marynen	51
15	A Human Homologue (BICD1) of theDrosophila Bicaudal-DGene 1997 ·Genomics ·Mathijs Baens, Peter Marynen	28
16	Genomic organization of TEL: the human ETS-variant gene 6. 1996 ·Genome Research ·Mathijs Baens, Pieter J. Peeters, Chunxue Guo, Jeroen Aerssens, Peter Marynen	100
17	Assignment of the Gene for the Human Proliferating Cell Nucleolar Protein P120 (NOL1) to Chromosome 12p13 by Fluorescence in Situ Hybridization and Polymerase Chain Reaction with Somatic Cell Hybrids 1994 ·Genomics ·Mathijs Baens, Max Chaffanet, Jeroen Aerssens, Jean‐Jacques Cassiman, Peter Marynen	4
18	Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization 1993 ·Tissue Antigens ·I. Buyse, Ronny Decorte, Mathijs Baens, Harry Cuppens, G. Sémana, Marie‐Paule Emonds, Peter Marynen, Jean-Jacques Cassiman	178
19	Simultaneous screening for 11 mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex amplification and reverse dot-blot 1992 ·Molecular and Cellular Probes ·Harry Cuppens, I. Buyse, Mathijs Baens, Peter Marynen, (unknown)	25
20	ALTERATION OF N‐RAS MUTATION IN A PATIENT WITH AML M4 AND TRILINEAGE MYELODYSPLASIA 1991 ·British Journal of Haematology ·Elisabeth Vandenberghe, Mathijs Baens, Michel Stul, André Bosly, J.J. Cassiman, Cristina Mecucci, Herman Van den Berghe	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact